Global Clinical Trial of Therapeutics for Severely-Ill Hospitalized COVID-19 Patients Begins at Intermountain
Researchers at Intermountain Healthcare are at the forefront of a new, multi-center National Institutes of Health study that is being launched across the nation to test the safety and efficacy of therapeutics for COVID-19 patients with life-threatening cases of the virus, including those with acute respiratory failure.
View full press release